|
|
SPOT ON
|
|
Rebates according to the Pharmaceutical Market Restructuring Act in Germany (AMNOG): how much money save the health insurance funds?
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Breast cancer: duration of adjuvant treatment with tamoxifen (NOLVADEX, generics)
|
|
|
NEW ON THE MARKET
|
|
Aflibercept (EYLEA) for exudative macular degeneration
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Emergency contraception - is prescription of levonorgestrel (PIDANA) instead of ulipristal acetate unethical?
|
|
|
IN BRIEF
|
|
Quality control of spironolactone tablets (ALDACTONE, generics)
Irrational penchant for dietary supplements
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Injection site abscess due to paliperidone depot (XEPLION)
Serious liver damage by abatacept (ORENCIA)
|
|
|
SIDE EFFECTS
|
|
Ethinyl estradiol plus cyproterone acetate (in DIANE, generics) in France off market
Lethal skin toxicity with tetrazepam (MUSARIL, generics)
|
|
|
e a-t IN INTERNET
|
|
CAVE: tianeptine (TIANEURAX) against depression
|
|